ArticleResearch (Washington, D.C.)2026

Dual-Pronged Lipid Nanocarriers Promote Immunotherapy for TNBC by Inducing Immunogenic Cell Death and Activating Lymphoid Immune Cells.

Jun Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.